Literature DB >> 9636285

Redox state of single chain Fv fragments targeted to the endoplasmic reticulum, cytosol and mitochondria.

S Biocca1, F Ruberti, M Tafani, P Pierandrei-Amaldi, A Cattaneo.   

Abstract

In this paper we have engineered the targeting of ScFv fragments to mitochondria and demonstrated that this can occur efficiently. This extends the range of subcellular compartments where antibody domains can be targeted in order to interfere with the action of the corresponding antigen. Moreover, we have compared the redox state of ScFv fragments targeted to the secretory compartment, the cytosol and the mitochondria, and demonstrated that cysteine residues in ScFv targeted to the secretory compartments and to the mitochondria are oxidized. On the contrary, cytosolic antibody domains are expressed in a reduced state, which is probably the reason for their lower expression levels. These pitfalls, however, do not prevent their successful utilization for intracellular immunization.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 9636285     DOI: 10.1038/nbt1095-1110

Source DB:  PubMed          Journal:  Biotechnology (N Y)        ISSN: 0733-222X


  35 in total

1.  Selection of antibodies for intracellular function using a two-hybrid in vivo system.

Authors:  M Visintin; E Tse; H Axelson; T H Rabbitts; A Cattaneo
Journal:  Proc Natl Acad Sci U S A       Date:  1999-10-12       Impact factor: 11.205

Review 2.  Generation of recombinant antibodies.

Authors:  S M Kipriyanov; M Little
Journal:  Mol Biotechnol       Date:  1999-09       Impact factor: 2.695

3.  Role of native-state topology in the stabilization of intracellular antibodies.

Authors:  G Settanni; A Cattaneo; A Maritan
Journal:  Biophys J       Date:  2001-11       Impact factor: 4.033

Review 4.  Targeting antibodies to the cytoplasm.

Authors:  Andrea L J Marschall; André Frenzel; Thomas Schirrmann; Manuela Schüngel; Stefan Dübel
Journal:  MAbs       Date:  2011-01-01       Impact factor: 5.857

5.  Inhibition of early and late events of the HIV-1 replication cycle by cytoplasmic Fab intrabodies against the matrix protein, p17.

Authors:  R Levin; A M Mhashilkar; T Dorfman; A Bukovsky; C Zani; J Bagley; J Hinkula; M Niedrig; J Albert; B Wahren; H G Göttlinger; W A Marasco
Journal:  Mol Med       Date:  1997-02       Impact factor: 6.354

6.  Apoplastic and cytosolic expression of full-size antibodies and antibody fragments in Nicotiana tabacum.

Authors:  S Schillberg; S Zimmermann; A Voss; R Fischer
Journal:  Transgenic Res       Date:  1999-08       Impact factor: 2.788

7.  Cell-permeable nanobodies for targeted immunolabelling and antigen manipulation in living cells.

Authors:  Henry D Herce; Dominik Schumacher; Anselm F L Schneider; Anne K Ludwig; Florian A Mann; Marion Fillies; Marc-André Kasper; Stefan Reinke; Eberhard Krause; Heinrich Leonhardt; M Cristina Cardoso; Christian P R Hackenberger
Journal:  Nat Chem       Date:  2017-07-17       Impact factor: 24.427

8.  Efficient isolation of soluble intracellular single-chain antibodies using the twin-arginine translocation machinery.

Authors:  Adam C Fisher; Matthew P DeLisa
Journal:  J Mol Biol       Date:  2008-11-01       Impact factor: 5.469

9.  Directed evolution of a fluorogen-activating single chain antibody for function and enhanced brightness in the cytoplasm.

Authors:  Bradley P Yates; Michelle A Peck; Peter B Berget
Journal:  Mol Biotechnol       Date:  2013-07       Impact factor: 2.695

10.  Targeting human immunodeficiency virus type 1 reverse transcriptase by intracellular expression of single-chain variable fragments to inhibit early stages of the viral life cycle.

Authors:  F Shaheen; L Duan; M Zhu; O Bagasra; R J Pomerantz
Journal:  J Virol       Date:  1996-06       Impact factor: 5.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.